|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-4-18
|
|
pubmed:abstractText |
To describe the probability of RILD by application of the Lyman-Kutcher-Burman normal-tissue complication (NTCP) model for primary liver carcinoma (PLC) treated with hypofractionated three-dimensional conformal radiotherapy (3D-CRT).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
pubmed-author:ChenLongL,
pubmed-author:FuXiao-LongXL,
pubmed-author:JiangGuo-LiangGL,
pubmed-author:LiangShi-XiongSX,
pubmed-author:LuHai-JieHJ,
pubmed-author:WangAn-YuAY,
pubmed-author:XuZhi-YongZY,
pubmed-author:YangYun-LiYL,
pubmed-author:ZhaoJian-DongJD,
pubmed-author:ZhuJiJ,
pubmed-author:ZhuXiao-DongXD
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
65
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
189-95
|
|
pubmed:dateRevised |
2007-11-6
|
|
pubmed:meshHeading |
pubmed-meshheading:16542787-Adult,
pubmed-meshheading:16542787-Aged,
pubmed-meshheading:16542787-Chemoembolization, Therapeutic,
pubmed-meshheading:16542787-Dose Fractionation,
pubmed-meshheading:16542787-Female,
pubmed-meshheading:16542787-Follow-Up Studies,
pubmed-meshheading:16542787-Humans,
pubmed-meshheading:16542787-Likelihood Functions,
pubmed-meshheading:16542787-Liver,
pubmed-meshheading:16542787-Liver Neoplasms,
pubmed-meshheading:16542787-Male,
pubmed-meshheading:16542787-Middle Aged,
pubmed-meshheading:16542787-Models, Biological,
pubmed-meshheading:16542787-Models, Statistical,
pubmed-meshheading:16542787-Radiation Injuries,
pubmed-meshheading:16542787-Radiation Tolerance,
pubmed-meshheading:16542787-Radiotherapy, Conformal
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Fudan University Cancer Hospital, Shanghai, China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
